HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

N- (5- (3- (3- hydroxypiperidin- 1- yl)- 1,2,4- oxadiazol- 5- yl)- 4- methyl- 1,3- thiazol- 2- yl)acetamide

anti-inflammatory agent that inhibits phosphoinositide 3-kinase; structure on first source

Also Known As:

TASP0415914

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Thiazoles: 392
      - N-(5-(3-(3-hydroxypiperidin-1-yl)-1,2,4-oxadiazol-5-yl)-4-methyl-1,3-thiazol-2-yl)acetamide: 1
    - Oxazoles: 89
      - Oxadiazoles: 146
        N-(5-(3-(3-hydroxypiperidin-1-yl)-1,2,4-oxadiazol-5-yl)-4-methyl-1,3-thiazol-2-yl)acetamide: 1
Organic Chemicals: 133
- Sulfur Compounds: 278
  - Thiazoles: 392
    - N-(5-(3-(3-hydroxypiperidin-1-yl)-1,2,4-oxadiazol-5-yl)-4-methyl-1,3-thiazol-2-yl)acetamide: 1

Experts

1.	Endo, Mayumi: 1 article (12/2013)
2.	Fujii, Yasuyuki: 1 article (12/2013)
3.	Fujita, Kiyoko: 1 article (12/2013)
4.	Inoue, Tomoyuki: 1 article (12/2013)
5.	Kimura, Kayo: 1 article (12/2013)
6.	Kuroda, Shoichi: 1 article (12/2013)
7.	Ohtake, Hidenori: 1 article (12/2013)
8.	Oi, Takahiro: 1 article (12/2013)
9.	Oka, Yusuke: 1 article (12/2013)
10.	Sekiguchi, Yoshinori: 1 article (12/2013)

Related Diseases

1.	Experimental Arthritis 12/15/2013 - "TASP0415914 demonstrated good potency in a cell-based assay and, furthermore, exhibited in vivo efficacy in a collagen induced arthritis (CIA) model in mice after oral administration. "

Related Therapies and Procedures

1.	Oral Administration